Small retrospective single-center cohort (n=13) with no comparator arm; safety and pain relief are encouraging but survival outcomes are modest and evidence requires prospective validation.
Meta-analysis of preclinical xenograft models demonstrates significant tumor suppression, but limited safety and translational data prevent clinical extrapolation.